Actively Recruiting
Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
Led by Queen Mary University of London · Updated on 2025-03-24
25000
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
Sponsors
Q
Queen Mary University of London
Lead Sponsor
A
Aga Khan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
We will determine how best to manage the hepatitis C virus (HCV) epidemic in Pakistan by measuring effectiveness of Pakistan-government sponsored current therapies, emergence of viral resistance, consequences of infection (chiefly liver cancer) and through developing models, based on incidence data, determine the proportion of people who need curative treatment to eliminate HCV, and assess whether targeting can optimise this.
CONDITIONS
Official Title
Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults over 18 years old
- Willing to undergo hepatitis C testing
- Able and willing to give informed consent
- Willing to return in 12 months time for repeat testing
- Resident in area and not planning to leave the region
You will not qualify if you...
- Unwilling to give consent
- Unwilling or unable to undergo the necessary procedures
- Clinically significant illness (other than HCV) or other major medical condition that may interfere with treatment, assessment, or compliance
- Co-morbidities limiting life expectancy to less than 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aga Khan University
Karachi, Pakistan
Actively Recruiting
Research Team
G
Graham R Foster, MBBS
CONTACT
N
Naheed Choudhry, Phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here